Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.

[1]  Prahlad T. Ram,et al.  Next‐generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma , 2016, The Journal of pathology.

[2]  H. Gollnick,et al.  Expression of epidermal stem cell markers in skin and adnexal malignancies , 2016 .

[3]  T. Tabone,et al.  Circumscribed sebaceous neoplasms: a morphological, immunohistochemical and molecular analysis. , 2016, Pathology.

[4]  H. Lee,et al.  Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases , 2016, Journal of pathology and translational medicine.

[5]  M. Kwon,et al.  Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value. , 2016, Human pathology.

[6]  R. F. Lam,et al.  Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid , 2015, Seminars in ophthalmology.

[7]  Ching-Yi Cheng,et al.  Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids , 2015, BMC Ophthalmology.

[8]  M. Kwon,et al.  Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation. , 2015, Human pathology.

[9]  M. Kwon,et al.  Comparison of HER2 gene amplification and KRAS alteration in eyelid sebaceous carcinomas with that in other eyelid tumors. , 2015, Pathology, research and practice.

[10]  D. Chang,et al.  Lynch‐like syndrome: Characterization and comparison with EPCAM deletion carriers , 2015, International journal of cancer.

[11]  Li-xu Yan,et al.  [Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma]. , 2015, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[12]  S. Lyle,et al.  BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis. , 2014, Human pathology.

[13]  K. Kuo,et al.  Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. , 2014, Human pathology.

[14]  F. Jakobiec,et al.  Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. , 2014, American journal of ophthalmology.

[15]  H. Choung,et al.  Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis. , 2014, Experimental eye research.

[16]  M. Cronauer,et al.  Overexpression of p16INK4a in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection , 2013, PloS one.

[17]  J. Irish,et al.  Identification of novel target proteins in sebaceous gland carcinoma , 2013, Head & neck.

[18]  M. Hata,et al.  Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. , 2012, International journal of radiation oncology, biology, physics.

[19]  M. Kwon,et al.  Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue. , 2011, Pathology, research and practice.

[20]  M. Bajaj,et al.  Does β-catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid? , 2010, British Journal of Ophthalmology.

[21]  H. Kutzner,et al.  Mutations in Exon 3 of the CTNNB1 Gene (β-Catenin Gene) in Cutaneous Adnexal Tumors , 2009, The American Journal of dermatopathology.

[22]  V. Grachtchouk,et al.  Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling , 2008, Nature Genetics.

[23]  Julia Song,et al.  Sebaceous Cell Carcinoma of the Ocular Adnexa: Clinical Presentations, Histopathology, and Outcomes , 2008, Ophthalmic plastic and reconstructive surgery.

[24]  B. Esmaeli,et al.  Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid , 2008, International journal of dermatology.

[25]  Lewis A. Chodosh,et al.  Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis , 2007, Nature Cell Biology.

[26]  S. Sułkowski,et al.  The expression of P53 protein and infection of human papilloma virus in conjunctival and eyelid neoplasms. , 2005, International journal of molecular medicine.

[27]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[28]  J. Sheu,et al.  Low mutation rate of hMSH2 and hMLH1 in Taiwanese hereditary non‐polyposis colorectal cancer , 2003, Clinical genetics.

[29]  R. Yeatts,et al.  5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. , 2000, Ophthalmology.

[30]  Philip R. Cohen,et al.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. , 1991, The American journal of medicine.

[31]  L. G. Kass,et al.  Sebaceous carcinoma of the ocular adnexa. , 1989, Survey of ophthalmology.

[32]  I. McLean,et al.  Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data. , 1982, Human pathology.

[33]  C. Gadeberg,et al.  Carcinoma of the eyelid. , 1978, Acta radiologica: oncology, radiation, physics, biology.

[34]  M. Schulz,et al.  Carcinoma of the eyelid; analysis of 301 cases and review of the literature. , 1949, The New England journal of medicine.